Study to Demonstrate the Maintenance Effect of Treatment and Confirm the Safety of DWP14012 in Patients With Healed Erosive Esophagitis Confirmed on EGD After Medication Treatment
Condition: Healed Erosive Esophagitis Interventions: Drug: DWP14012 X mg; Drug: DWP14012 Xmg placebo; Drug: Lansoprazole 15 mg; Drug: Lansoprazole 15 mg Placebo Sponsor: Daewoong Pharmaceutical Co. LTD. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials